Last reviewed · How we verify
CHEMBL110094 — Competitive Intelligence Brief
phase 1
Live · refreshed every 30 min
Target snapshot
CHEMBL110094 (CHEMBL110094).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CHEMBL110094 TARGET | CHEMBL110094 | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CHEMBL110094 CI watch — RSS
- CHEMBL110094 CI watch — Atom
- CHEMBL110094 CI watch — JSON
- CHEMBL110094 alone — RSS
Cite this brief
Drug Landscape (2026). CHEMBL110094 — Competitive Intelligence Brief. https://druglandscape.com/ci/chembl110094. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing